Antimicrobial photodynamic therapy mediated by methylene blue and potassium iodide to treat urinary tract infection in a female rat model (2018)

Peer-Reviewed Study · Huang YY, Wintner A, Seed PC, et al. · May 8, 2018

Huang YY et al., 2018-05-08: Rat study of intravesical methylene blue plus potassium iodide with 660 nm light for E. coli urinary infection, finding light-dose-dependent bacterial reduction and shorter infection duration. The only bladder-instillation evidence located, and it is animal.

In the intact rat model we introduced MB into the bladder by catheter, followed by KI solution and delivered intravesicular illumination with a diffusing fiber connected to a 1 W 660 nm laser.

Huang YY et al., 2018-05-08: Rat study of intravesical methylene blue plus potassium iodide with 660 nm light for E. coli urinary infection, finding light-dose-dependent bacterial reduction and shorter infection duration. The only bladder-instillation evidence located, and it is animal. Study type: animal (female rat UTI model, bioluminescent UPEC). N not stated in abstract. Country: USA (Massachusetts General Hospital/Harvard). MB instilled intravesically by catheter, then KI; 1 W 660 nm laser via diffusing fibre; light doses varied. Funding: not stated in record. Conflicts: not stated. Comparator: untreated controls and MB alone. Establishes the principle of intravesical MB photodynamic therapy, not human efficacy. Also filed as MTL-083 (claims C5, C7). Study type: animal.